Glanders

Journal of the American Veterinary Medical Association

Volumn 233, Issue 4, 2008, Pages 570-577

  Dvorak, Glenda D ^a   Spickler, Anna R ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; BIOLOGICAL WARFARE; BURKHOLDERIA MALLEI; DISEASE TRANSMISSION; EPIDEMIC; HORSE; HORSE DISEASE; HUMAN; PATHOGENICITY; PUBLIC HEALTH; REVIEW; SPECIES DIFFERENCE; ZOONOSIS;

ANIMALS; BIOTERRORISM; BURKHOLDERIA MALLEI; DISEASE OUTBREAKS; EQUIDAE; GLANDERS; HORSES; HUMANS; PUBLIC HEALTH; SPECIES SPECIFICITY; ZOONOSES;

EQUIDAE;

EID: 50449096767     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.233.4.570     Document Type: Review

References (86)

1. Blue SR, Pombo DJ, Woods ML. Glanders and melioidosis. In: Palmer SR, Soulsby L, Simpson DIH, eds. Zoonoses: biology, clinical practice and public health control. Oxford, England: Oxford University Press, 1998;105-113.
2. Howe C, Sampath A, Spotnitz M. The Pseudomallei group: a review. J Infect Dis 1971;124:598-606.
3. Groves MG, Harrington KS. Glanders and melioidosis. In: Beran GW, Steele JH, eds. Handbook of zoonoses. Section A: bacterial, rickettsial, chlamydial, and mycotic. 2nd ed. Boca Raton, Fla: CRC Press, 1994;149-155.
4. Nicoletti PL. Glanders. In: Sellon DC, Long MT, eds. Equine infectious diseases. 9th ed. St Louis: Saunders, 2007;345-348.
5. Van Der Lugt JJ, Bishop GC. Glanders. In: Coetzer JAW, Tustin RC, eds. Infectious diseases of livestock. 2nd ed. Oxford, England: Oxford University Press, 2004;1500-1504.
6. Pitt TL. Pseudomonas, Burkholderia and related genera. In: Collier L, Balows A, Sussman M, eds. Topley & Wilson's microbiology and microbial infections. 9th ed. London: Oxford University Press, 1998;1123-1126.
7. Yabuuchi E, Kosako Y, Oyaizu H, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992;36:1251-1275.
8. Godoy D, Randle G, Simpson AJ, et al. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 2003;41:2068-2079.
9. Waag DM, DeShazer D. Glanders: new insights into an old disease. In: Lindler LE, Lebeda FJ, Korch GW eds. Biological weapons defense: infectious diseases and counter bioterrorism. Totowa, NJ: Humana Press, 2004;209-237.
10. Holden MT, Titball RW, Peacock SJ, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 2004;101:14240-14245.
11. Kim HS, Schell MA, Yu Y, et al. Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. BMC Genomics 2005;6:174-187.
12. Nierman WC, DeShazer D, Kim HS, et al. Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci U S A 2004;101:14246-14251.
13. Moore RA, Reckseidler-Zenteno S, Kim H, et al. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun 2004;72:4172-4187.
14. Public Health Agency of Canada. Material safety data sheet - Burkholderia (Pseudomonas) mallei. Office of Laboratory Security; 1999 Nov. Available at: www.phac-aspc.gc.ca/msds-ftss/ms-ds25e.html. Accessed Aug 27, 2007.
15. Gilbert RO. Glanders. In: Foreign animal diseases. The gray book. Richmond, Va: United States Animal Health Association, 1998. Available at: www.vet.uga.edu/vpp/gray_book02/fad/gla.php. Accessed Aug 27, 2007.
16. Brett PJ, Burtnick MN, Snyder DS, et al. Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol Microbiol 2007;63:379-390.
17. DeShazer D, Waag DM, Fritz DL, et al. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 2001;30:253-269.
18. Schell MA, Ulrich RL, Ribot WJ, et al. Type VI secretion is a major virulence determination in Burkholderia mallei. Mol Microbiol 2007;64:1466-1485.
19. Woods DE. The use of animal infection models to study the pathogenesis of melioidosis and glanders. Trends Microbiol 2002;10:483-484.
20. Ribot WJ, Ulrich RL. The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. Infect Immun 2006;74:4349-4353.
21. Ulrich RL, DeShazer D. Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 2004;72:1150-1154.
22. Ulrich RL, DeShazer D, Hines HB, et al. Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. Infect Immun 2004;72:6589-6596.
23. Fritz DL, Vogel P, Brown DR, et al. The hamster model of intraperitoneal Burkholderia mallei (glanders). Vet Pathol 1999;36:276-291.
24. Fritz DL, Vogel P, Brown DR, et al. Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet Pathol 2000;37:626-636.
25. Whitlock GC, Estes DM, Torres AG. Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 2007;277:115-122.
26. Dance DAB. Melioidosis and glanders as possible biological weapons. In: Fong IW, Alibek K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York: Springer, 2005;99-143.
27. Acha PN, Szyfres B. Glanders. In: Zoonoses and communicable diseases common to man and animals. 2nd ed. Washington, DC: Pan American Health Organization, 1989;86-89.
28. Blancou J. Early methods for the surveillance and control of glanders in Europe. Rev Sci Tech Off Int Epiz 1994;13:545-557.
29. APHIS, USDA. APHIS history. Available at: permanent.access.gpo.gov/ lps3025/history.html. Accessed Dec 4, 2007.
30. Neubauer H, Sprague LD, Zacharia R, et al. Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. J Vet Med B Infect Dis Vet Public Health 2005;52:201-205.
31. Derbyshire JB. The eradication of glanders in Canada. Can Vet J 2002;43:722-726.
32. World Organization for Animal Health (OIE). Glanders. In: Manual of diagnostic tests and vaccines for terrestrial animals. Paris: OIE, 2004. Available at: www.oie.int/eng/normes/mmanual/A_00086.htm. Accessed Aug 24, 2007.
33. Al-Ani FK, Roberson J. Glanders in horses: a review of the literature. Veterinarski Arh 2007;77:203-218.
34. Lopez A. Respiratory disease. In: McGavin MD, Zachary JF, eds. Pathologic basis of veterinary disease. 4th ed. St Louis: Mosby/Elsevier, 2007;478-479.
35. Arun S, Neubauer H, Gürel A, et al. Equine glanders in Turkey. Vet Rec 1999;144:255-258.
36. ProMED Mail. Glanders - Brazil (South). Aug 15, 2004. Archive No. 20040815.2265. Available at: www.promedmail.org. Accessed Aug 31, 2007.
37. ProMED Mail. Glanders, equine - Russia (Chita). July 7, 2007. Archive No. 20070707.2167. Available at: www.promedmail.org. Accessed Aug 31, 2007.
38. ProMED Mail. Glanders, Equine - Iran ex Iraq. Nov 29, 2007. Archive No. 20071129.3854. Available at: promedmail.org. Accessed Dec 4, 2007.
39. World Organization for Animal Health (OIE). Handistatus II [database online]. Paris: OIE, 2004. Available at: www.oie.int/hs2/report.asp?lang=en. Accessed Dec 2, 2007.
40. World Organization for Animal Health (OIE). Diseases of the OIE classification. Available at: www.oie.int/eng/maladies/en_classification.htm. Accessed Dec 4, 2007.
41. Sharrer GT. The great glanders epizootic, 1861-1866: a Civil War legacy. Agric Hist 1995;69:79-97.
42. Graber MA. Burkholderia mallei (glanders) attack. In: Ciottone GR, Anderson PD, Auf Der Heide E, et al, eds. Disaster medicine. 3rd ed. Philadelphia: Mosby/Elsevier, 2006;647-649.
43. CDC. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 2000;49(RR-4):1-14.
44. Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8:225-230.
45. Redfearn MS, Palleroni NJ. Glanders and melioidosis. In: Hubbert WT, McCulloch WF, Schnurrenberger PR, eds. Diseases transmitted from animals to man. 6th ed. Springfield, Ill: Charles C. Thomas, 1975;110-128.
46. Biberstein EL, Holzworth J. Bacterial diseases: glanders. In: Holzworth J, ed. Diseases of the cat: medicine and surgery. Philadelphia: WB Saunders Co, 1987;296.
47. Vyshelesskii SN. Glanders (Equinia). Tr Vsesoiuznyi Inst Eksperimental'noi Veterinarii 1974;42:67-92.
48. Alibasoglu M, Yesildere T, Calislar T, et al. Glanders outbreak in lions in the Istanbul zoological gardens. Berl Munch Tierarztl Wochenschr 1986;99:57-63.
49. Battelli C, Contento F, Corsalini T, et al. Glanders in a group of lions in captivity. Vet Ital 1973;24:87-112, 113-116.
50. Lever MS, Nelson M, Ireland PI, et al. Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse. J Med Microbiol 2003;52:1109-1115.
51. Treviño SR, Permenter AR, England MJ, et al. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect Immun 2006;74:1958-1961.
52. Rusnak JM, Kortepeter MG, Hawley RJ, et al. Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers. Biosecur Bioterror 2004;2:281-293.
53. McGilvray CD. The transmission of glanders from horse to man. Can J Public Health 1944;35:268-275.
54. Bernstein JM, Carling ER. Observations on human glanders: with a study of six cases and a discussion of the methods of diagnosis. BMJ 1909;1:319-325.
55. Howe C, Miller WR. Human glanders: report of six cases. Ann Intern Med 1947;26:93-115.
56. Srinivasan A, Kraus CN, DeShazer D, et al. Glanders in a military research microbiologist. N Engl J Med 2001;345:256-258.
57. DeShazer D, Byrne WR, Culpepper R, et al. Laboratory-acquired human glanders - Maryland, May 2000. MMWR Morb Mortal Wkly Rep 2000;49:532-535.
58. Bossi P, Tegnell A, Baka A, et al. Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis. Euro Surveill 2004;9:E17-E18.
59. Lopez J, Copps J, Wilhelmsen C, et al. Characterization of experimental equine glanders. Microbes Infect 2003;5:1125-1131.
60. Zubaidy AJ, Al-Ani FK. Pathology of glanders in horses in Iraq. Vet Pathol 1978;15:566-568.
61. Muhammad G, Khan M, Athar M. Clinico-microbiological and therapeutic aspects of glanders in equine. J Equine Sci 1998;9:93-96.
62. Anuntagool N, Sirisinha S. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei. Microbiol Immunol 2002;46:143-150.
63. Sprague LD, Zysk G, Hagen RM, et al. A possible pitfall in the identification of Burkholderia mallei using molecular identification systems based on the sequence of the flagellin fliC gene. FEMS Immunol Med Microbiol 2002;34:231-234.
64. Xie X, Xu F, Xu B, et al. A new selective medium for isolation of glanders bacilli. In: Collected papers of veterinary research. Vol 6. Peking: Control Institute of Veterinary Biologies, Ministry of Agriculture, 1980;83-90.
65. Glass MB, Popovic T. Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2005;43:479-483.
66. Hagebock JM, Schlater LK, Frerichs WM, et al. Serologic responses to the mallein test for glanders in solipeds. J Vet Diagn Invest 1993;5:97-99.
67. Naureen A, Saquib M, Muhammad G, et al. Comparative evaluation of rose bengal plate agglutination test, mallein test and some conventional serological tests for diagnosis of equine glanders. J Vet Diagn Invest 2007;19:362-367.
68. Jana AM, Gupta AK, Pandya G, et al. Rapid diagnosis of glanders in equines by counter-immunoelectrophoresis. Indian Vet J 1982;59:5-9.
69. Al-Ani FK. Glanders in horses: a review. Sudan J Vet Sci Anim Husbandry 1993;32:1-10.
70. Verma RD, Sharma JK, Venkateswaran KS, et al. Development of an avidin-biotin dot enzyme-linked immunosorbent assay and its comparison with other serological tests for diagnosis of glanders in equines. Vet Microbiol 1990;25:77-85.
71. M'Fadyean J. Preliminary note on the sero-diagnosis of glander. J Comp Pathol Ther 1896;9:322-323.
72. Cravitz L, Miller WR. Immunologic studies with Malleomyces mallei and Malleomyces pseudomallei. I. Serological relationships between M. mallei and M. pseudomallei. J Infect Dis 1950;86:46-51.
73. Tomaso H, Scholz HC, Al Dahouk S, et al. Development of 5′ nucleases real-time PCR assays for the rapid identification of the Burkholderia mallei/Burkholderia pseudomallei complex. Diagn Mol Pathol 2004;13:247-253.
74. Lee MA, Wang D, Yap EH. Detection and differentiation of Burkholderia pseudomallei, Burkholderia mallei and Burkholderia thailandensis by multiplex PCR. FEMS Immunol Med Microbiol 2005;43:413-417.
75. Ulrich MP, Norwood DA, Christensen DR, et al. Using real-time PCR to specifically detect Burkholderia mallei. J Med Microbiol 2006;55:551-559.
76. Wattiau P, Van Hessche M, Neubauer H, et al. Identification of Burkholderia pseudomallei and related bacteria by multiple-locus sequence typing-derived PCR and real-time PCR. J Clin Microbiol 2007;45:1045-1048.
77. Scholz HC, Joseph M, Tomaso H, et al. Detection of the reemerging agent Burkholderia mallei in a recent outbreak of glanders in the United Arab Emirates by a newly developed flip-based polymerase chain reaction assay. Diagn Microbiol Infect Dis 2006;54:241-247.
78. Chantratita N, Vesaratchavest M, Wuthiekanun V, et al. Pulsed-field gel electrophoresis as a discriminatory typing technique for the biothreat agent Burkholderia mallei. Am J Trop Med Hyg 2006;74:345-347.
79. Gee JE, Sacchi CT, Glass MB, et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2003;41:4647-4654.
80. Lew AE, Desmarchelier PM. Molecular typing of Pseudomonas pseudomallei: restriction fragment length polymorphisms of rRNA genes. J Clin Microbiol 1993;31:533-539.
81. Parthasarathy N, DeShazer D, England M, et al. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies. Diagn Microbiol Infect Dis 2006;56:329-332.
82. Thibault FM, Hernandez E, Vidal DR, et al. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 2004;54:1134-1138.
83. Russell P, Eley SM, Ellis J, et al. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. J Antimicrob Chemother 2000;45:813-818.
84. Kenny DJ, Russel P, Rogers D, et al. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob Agents Chemother 1999;43:2773-2775.
85. Heine HS, England MJ, Waag DM, et al. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob Agents Chemother 2001;45:2119-2121.
86. US Government Printing Office. Electronic Code of Federal Regulations Web site. Horses. Title 9, chapter 1, part 93, subpart C. Available at: ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid= 7a8b007b28740a9b44bf483894a20760&rgn=div5&view=text&node=9:1.0.1.4. 33&idno=9#9:1.0.1.4.33.3. Accessed July 2, 2008.